Natera Q4 2023 Earnings Presentation - NTRA Investor Call

Natera reported Q4 2023 revenue of $311M (43% YoY growth) and full-year revenue of $1.08B with improving gross margins reaching 45.5%. The company highlighted strategic acquisitions, expanded Medicare coverage for Signatera oncology testing, and significant progress in organ health clinical trials, projecting breakeven by Q3 2024.